Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key ...

The upcoming 15th Annual Outsourcing in Clinical Trials Europe conference will cover a wide range of topics on clinical ...

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.

In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), discusses numerous themes that clin ops can focus on to keep its trials running efficiently and ...

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

Medical teams are also important players ... we can ensure that clinical trials reflect the full spectrum of human diversity and lead to better health outcomes for all.

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving ...

First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients: United Kingdom Friday, April 11, 2025, 18:00 Hrs [I ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, particularly in phase III psoriasis trials.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Clinical research continues to struggle with ... lifecycle is clearly associated with greater levels of diversity in patients and is an important way of ensuring that representation within trial ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...